Front Pharmacol
From Bioblast
Revision as of 12:38, 26 January 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Journal |Title=[https://www.frontiersin.org/journals/pharmacology# Frontiers in Pharmacology] }}")
Journal title and website | Frontiers in Pharmacology |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Pena-Corona 2023 Front Pharmacol | Peña-Corona SI, Hernández-Parra H, Bernal-Chávez SA, Mendoza-Muñoz N, Romero-Montero A, Del Prado-Audelo ML, Cortés H, Ateşşahin DA, Habtemariam S, Almarhoon ZM, Abdull Razis AF, Modu B, Sharifi-Rad J, Leyva-Gómez G (2023) Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents. Front Pharmacol 14:1206334. https://doi.org/10.3389/fphar.2023.1206334 | 2023 | PMID: 37346293 Open Access |
Vidimce 2021 Front Pharmacol | Vidimce J, Pillay J, Shrestha N, Dong LF, Neuzil J, Wagner KH, Holland OJ, Bulmer AC (2021) Mitochondrial function, fatty acid metabolism, and body composition in the hyperbilirubinemic gunn rat. Front Pharmacol 12:586715. | 2021 | PMID: 33762933 Open Access |
Gatti 2020 Front Pharmacol | Gatti P, Ilamathi HS, Todkar K, Germain M (2020) Mitochondria targeted viral replication and survival strategies-prospective on SARS-CoV-2. Front Pharmacol 11:578599. https://doi.org/10.3389/fphar.2020.578599 | 2020 | PMID: 32982760 Open Access |
Busanello 2017 Front Pharmacol | Busanello ENB, Marques AC, Lander N, de Oliveira DN, Catharino RR, Oliveira HCF, Vercesi AE (2017) Pravastatin chronic treatment sensitizes hypercholesterolemic mice muscle to mitochondrial permeability transition: protection by creatine or coenzyme Q10. Front Pharmacol 8:185. | 2017 | PMID: 28424622 Open Access |
Ren 2017 Front Pharmacol | Ren YJ, Wang XH, Ji C, Guan YD, Lu XJ, Liu XR, Zhang HH, Guo LC, Xu QH, Zhu WD, Ming ZJ, Yang JM, Cheng Y, Zhang Y (2017) Silencing of NAC1 expression induces cancer cells oxidative stress in hypoxia and potentiates the therapeutic activity of elesclomol. Front Pharmacol 8:804. | 2017 | PMID: 29163184 Open Access |